RANIBIZUMAB

26488 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking RANIBIZUMAB:

# Side effect Count
0 DEATH 3804
1 VISUAL ACUITY REDUCED 2893
2 OFF LABEL USE 1747
3 VISUAL IMPAIRMENT 1677
4 CEREBROVASCULAR ACCIDENT 1239
5 DRUG INEFFECTIVE 1213
6 NO ADVERSE EVENT 1061
7 BLINDNESS 1051
8 EYE HAEMORRHAGE 1050
9 VISION BLURRED 1036
See all common reactions for RANIBIZUMAB

RANIBIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POLYPOIDAL CHOROIDAL VASCULOPATHY 199 0.6419
1 RETINAL PIGMENT EPITHELIAL TEAR 322 0.4640
2 DIABETIC RETINAL OEDEMA 229 0.4508
3 SUBRETINAL FIBROSIS 83 0.4256
4 CHOROIDAL NEOVASCULARISATION 359 0.4184
5 MACULAR SCAR 73 0.3763
6 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 312 0.3506
7 RETINAL SCAR 154 0.3341
8 RETINAL CYST 54 0.3253
9 SUBRETINAL FLUID 338 0.3092
See all enriched reactions for RANIBIZUMAB